Zimmer Biomet (NYSE:ZBH) capped off the American Orthopedic Surgery Society’s annual meeting this week by inking a deal to distribute CelgenTek Innovations Corp.’s bone trauma technology and the launch of new Persona and OsseoTi knee components. The Warsaw, Ind.-based orthopedics juggernaut said the deal with CelgenTek includes that company’s N-Force fixation system and iN3 cement for […]
ConforMIS (NSDQ:CFMS) leveled a lawsuit against Smith & Nephew (NYSE:SNN) this week, accusing the British orthopedics giant of trespassing on 8 patents covering the ConforMIS technology for patient-specific knee implants. Bedford, Mass.-based ConforMIS also launched its iTotal PS, claiming it as the only customized posterior stabilized knee replacement system on the market. The lawsuit against Smith & Nephew, filed in […]
Belgium-based additive manufacturer and 3D printing company Materialise (NSDQ:MTLS) said the FDA sent it a “not substantially equivalent” letter for its X-ray knee guide system, dooming its bid for 510(k) clearance from the federal safety watchdog. The Materialise system is designed to help align total knee replacement components without MRI or CT scans, the company said. […]
The knee replacement market has reached stratospheric levels in the U.S., with competitors ranging from Zimmer Biomet (NYSE:ZBH) to Smith & Nephew (NYSE:SNN) and Johnson & Johnson (NYSE:JNJ). California device developer Moximed is betting its future, however, on patients not quite ready for the drastic surgery. The knee replacement market is worth an estimated $4 billion […]
An Illinois jury last week cleared Zimmer Biomet (NYSE:ZBH) in the 1st bellwether trial of the more than 900 lawsuits lodged over its NexGen Flex knee replacements. Plaintiff Kathy Batty alleged that the double knee replacements she had in 2009 using the NexGen Flex implants failed, requiring revision surgeries after 2 years. But the jury in the U.S. District […]
Ceterix Orthopaedics said last week that it took out a $35 million term loan with CRG it plans to use to advance its NovoStitch suture passing device for surgeries to repair torn menisces in the knee.
Menlo Park, Calif.-based Ceterix said the NovoStitch device is designed to help surgeons place sutures in patterns that used to require open procedures or weren’t possible at all.
Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.
OrthoSensor said today that it closed out a $19 million Series C round it plans to use to commercialize its Verasense knee implant technology.
Dania Beach, Fla.-based OrthoSensor said Bridger Healthcare and the Tullis Growth Fund participated in the round.
After a 7-year run Fall River, Mass.-based NuOrtho Surgical filed for Chapter 7 bankruptcy, listing liabilities of $4.74 million and assets of $287,117. Nearly 40 patents were also cited in the filing, some of which had been used as collateral.